636 related articles for article (PubMed ID: 28525743)
1. Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function.
Sakamaki JI; Wilkinson S; Hahn M; Tasdemir N; O'Prey J; Clark W; Hedley A; Nixon C; Long JS; New M; Van Acker T; Tooze SA; Lowe SW; Dikic I; Ryan KM
Mol Cell; 2017 May; 66(4):517-532.e9. PubMed ID: 28525743
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of autophagy and lysosomal function by bromodomain protein BRD4.
Sakamaki JI; Ryan KM
Autophagy; 2017; 13(11):2006-2007. PubMed ID: 28933601
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism.
Perera RM; Stoykova S; Nicolay BN; Ross KN; Fitamant J; Boukhali M; Lengrand J; Deshpande V; Selig MK; Ferrone CR; Settleman J; Stephanopoulos G; Dyson NJ; Zoncu R; Ramaswamy S; Haas W; Bardeesy N
Nature; 2015 Aug; 524(7565):361-5. PubMed ID: 26168401
[TBL] [Abstract][Full Text] [Related]
4. BRD4 is a newly characterized transcriptional regulator that represses autophagy and lysosomal function.
Wen X; Klionsky DJ
Autophagy; 2017; 13(11):1801-1803. PubMed ID: 28837371
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic analysis of the role of bromodomain-containing protein 4 (BRD4) in BRD4-NUT oncoprotein-induced transcriptional activation.
Wang R; You J
J Biol Chem; 2015 Jan; 290(5):2744-58. PubMed ID: 25512383
[TBL] [Abstract][Full Text] [Related]
6. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma.
Alekseyenko AA; Walsh EM; Zee BM; Pakozdi T; Hsi P; Lemieux ME; Dal Cin P; Ince TA; Kharchenko PV; Kuroda MI; French CA
Proc Natl Acad Sci U S A; 2017 May; 114(21):E4184-E4192. PubMed ID: 28484033
[TBL] [Abstract][Full Text] [Related]
7. Drosophila Mitf regulates the V-ATPase and the lysosomal-autophagic pathway.
Bouché V; Espinosa AP; Leone L; Sardiello M; Ballabio A; Botas J
Autophagy; 2016; 12(3):484-98. PubMed ID: 26761346
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer.
Onishi H; Yamasaki A; Kawamoto M; Imaizumi A; Katano M
Cancer Lett; 2016 Feb; 371(2):143-50. PubMed ID: 26655998
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling.
Huang B; Cheng X; Wang D; Peng M; Xue Z; Da Y; Zhang N; Yao Z; Li M; Xu A; Zhang R
Oncotarget; 2014 Jul; 5(13):4732-45. PubMed ID: 25051362
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of autophagy by the methyltransferase G9a.
Artal-Martinez de Narvajas A; Gomez TS; Zhang JS; Mann AO; Taoda Y; Gorman JA; Herreros-Villanueva M; Gress TM; Ellenrieder V; Bujanda L; Kim DH; Kozikowski AP; Koenig A; Billadeau DD
Mol Cell Biol; 2013 Oct; 33(20):3983-93. PubMed ID: 23918802
[TBL] [Abstract][Full Text] [Related]
11. G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma.
Li F; Zeng J; Gao Y; Guan Z; Ma Z; Shi Q; Du C; Jia J; Xu S; Wang X; Chang L; He D; Guo P
PLoS One; 2015; 10(9):e0138390. PubMed ID: 26397365
[TBL] [Abstract][Full Text] [Related]
12. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation.
Wu SY; Chiang CM
J Biol Chem; 2007 May; 282(18):13141-5. PubMed ID: 17329240
[TBL] [Abstract][Full Text] [Related]
13. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
14. Emerging roles of transcriptional programs in autophagy regulation.
Sakamaki JI; Long JS; New M; Van Acker T; Tooze SA; Ryan KM
Transcription; 2018; 9(2):131-136. PubMed ID: 28980873
[TBL] [Abstract][Full Text] [Related]
15. AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.
Rhyasen GW; Hattersley MM; Yao Y; Dulak A; Wang W; Petteruti P; Dale IL; Boiko S; Cheung T; Zhang J; Wen S; Castriotta L; Lawson D; Collins M; Bao L; Ahdesmaki MJ; Walker G; O'Connor G; Yeh TC; Rabow AA; Dry JR; Reimer C; Lyne P; Mills GB; Fawell SE; Waring MJ; Zinda M; Clark E; Chen H
Mol Cancer Ther; 2016 Nov; 15(11):2563-2574. PubMed ID: 27573426
[TBL] [Abstract][Full Text] [Related]
16. Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy.
Li X; Yu W; Qian X; Xia Y; Zheng Y; Lee JH; Li W; Lyu J; Rao G; Zhang X; Qian CN; Rozen SG; Jiang T; Lu Z
Mol Cell; 2017 Jun; 66(5):684-697.e9. PubMed ID: 28552616
[TBL] [Abstract][Full Text] [Related]
17. Histone cross-talk connects protein phosphatase 1α (PP1α) and histone deacetylase (HDAC) pathways to regulate the functional transition of bromodomain-containing 4 (BRD4) for inducible gene expression.
Hu X; Lu X; Liu R; Ai N; Cao Z; Li Y; Liu J; Yu B; Liu K; Wang H; Zhou C; Wang Y; Han A; Ding F; Chen R
J Biol Chem; 2014 Aug; 289(33):23154-23167. PubMed ID: 24939842
[TBL] [Abstract][Full Text] [Related]
18. Uncovering BRD4 hyperphosphorylation associated with cellular transformation in NUT midline carcinoma.
Wang R; Cao XJ; Kulej K; Liu W; Ma T; MacDonald M; Chiang CM; Garcia BA; You J
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5352-E5361. PubMed ID: 28630312
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner.
Mishra VK; Wegwitz F; Kosinsky RL; Sen M; Baumgartner R; Wulff T; Siveke JT; Schildhaus HU; Najafova Z; Kari V; Kohlhof H; Hessmann E; Johnsen SA
Nucleic Acids Res; 2017 Jun; 45(11):6334-6349. PubMed ID: 28369619
[TBL] [Abstract][Full Text] [Related]
20. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.
French CA; Ramirez CL; Kolmakova J; Hickman TT; Cameron MJ; Thyne ME; Kutok JL; Toretsky JA; Tadavarthy AK; Kees UR; Fletcher JA; Aster JC
Oncogene; 2008 Apr; 27(15):2237-42. PubMed ID: 17934517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
